Search - tctmd.com

Displaying 1 - 20 of 1054

Sort: Relevancy | Date

News Featured Fellow

Revathy Sampath-Kumar, MD

Yael L. Maxwell

January 13, 2026

Presentation TCT 2025

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 1425: Transfemoral Transcatheter Aortic Valve Implantation in Severe Aortic Regurgitation (AR) Due to Aortic Valve Leaflet Perforation: Pure AR-Dedicated Device

Presenter: Ho On Alston Conrad Chiu

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

Presentation TCT 2025

TCT 720: Comparative Study of Single- versus Double-ProGlide Device Strategy for Access Site Closure of Transfemoral Transcatheter Aortic Valve Replacement

Presenter: Xianbao Liu

October 27, 2025

Presentation TCT 2025

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

The Transfemoral TaurusNXT TAVR System (Peijia Medical): Two-Year Results of the NXT-DURA Trial

Presenter: Wenzhi Pan

October 27, 2025

News Conference News TCT 2025

Left Distal Radial Access Doesn’t Reduce Radiation for Operators: DOSE

Caitlin E. Cox

October 25, 2025

Presentation TCT 2025

TCT 1531: Transfemoral Tricuspid Valve-in-Valve (ViV) Procedure in a High-Risk Patient With Bioprosthetic Valve Failure and Prior Infective Endocarditis

Presenter: Khin May Thaw

October 25, 2025

Presentation TCT 2025

TCT 1146: Transfemoral Transcatheter Aortic Valve Replacement in native aortic valves with small annuli: comparison of self-expandable and balloon-expandable vales.

Presenter: Kimberley Hemelrijk

October 25, 2025

Presentation TCT 2025

TCT 219: The TWIST Study: One-year Results of Transfemoral Transcatheter Mitral Valve Replacement with the INNOVALVE System

Presenter: Chet Rihal

October 25, 2025

News Conference News ESC 2025

DOUBLE-CHOICE: Minimalist Anesthesia for TAVI Comparable to Standard Care

Todd Neale

August 30, 2025

Podcast TCTMD Talking Points

Insights on Intrepid 2-Yr Mitral TF EFS

July 30, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

Presentation NY Valves 2025

Safety and Efficacy of Covered Stents for Managing Vascular Access Complications After Transfemoral Transcatheter Aortic Valve Replacements: A Systematic Review and Meta-analysis

Presenter: Osama Elkhateeb

June 27, 2025

Presentation NY Valves 2025

Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study

Presenter: Gilbert H. L. Tang

June 27, 2025

Presentation NY Valves 2025

Transradial vs Transfemoral Secondary Access for Transfemoral TAVR

Presenter: Chidubem Ezenna

June 27, 2025

Presentation NY Valves 2025

Case 2: When Transfemoral Access is Not Straightforward: Where Do We Go?

Presenter: Samineh Sehatbakhsh

June 27, 2025

Presentation NY Valves 2025

Innostay (Innovalve/Edwards)

Presenter: Chet Rihal

June 26, 2025

Presentation NY Valves 2025

AltaValve (4C Medical)

Presenter: Vlasis Ninios

June 26, 2025

Advertisement

Revathy Sampath-Kumar, MD

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

TCT 1425: Transfemoral Transcatheter Aortic Valve Implantation in Severe Aortic Regurgitation (AR) Due to Aortic Valve Leaflet Perforation: Pure AR-Dedicated Device

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

TCT 720: Comparative Study of Single- versus Double-ProGlide Device Strategy for Access Site Closure of Transfemoral Transcatheter Aortic Valve Replacement

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

The Transfemoral TaurusNXT TAVR System (Peijia Medical): Two-Year Results of the NXT-DURA Trial

Left Distal Radial Access Doesn’t Reduce Radiation for Operators: DOSE

TCT 1531: Transfemoral Tricuspid Valve-in-Valve (ViV) Procedure in a High-Risk Patient With Bioprosthetic Valve Failure and Prior Infective Endocarditis

TCT 1146: Transfemoral Transcatheter Aortic Valve Replacement in native aortic valves with small annuli: comparison of self-expandable and balloon-expandable vales.

TCT 219: The TWIST Study: One-year Results of Transfemoral Transcatheter Mitral Valve Replacement with the INNOVALVE System

DOUBLE-CHOICE: Minimalist Anesthesia for TAVI Comparable to Standard Care

Insights on Intrepid 2-Yr Mitral TF EFS

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Safety and Efficacy of Covered Stents for Managing Vascular Access Complications After Transfemoral Transcatheter Aortic Valve Replacements: A Systematic Review and Meta-analysis

Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study

Transradial vs Transfemoral Secondary Access for Transfemoral TAVR

Case 2: When Transfemoral Access is Not Straightforward: Where Do We Go?

Innostay (Innovalve/Edwards)

AltaValve (4C Medical)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content